These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
400 related articles for article (PubMed ID: 9559403)
21. HIV-1 co-infection in children hospitalised with tuberculosis in South Africa. Madhi SA; Huebner RE; Doedens L; Aduc T; Wesley D; Cooper PA Int J Tuberc Lung Dis; 2000 May; 4(5):448-54. PubMed ID: 10815739 [TBL] [Abstract][Full Text] [Related]
22. Should absolute lymphocyte count be used as a surrogate marker for CD4+ count in patients with HIV/AIDS? Jibrin YB; Yusuph H; Garbati MA; Gashau W; Abja UM Afr J Med Med Sci; 2006 Mar; 35(1):9-13. PubMed ID: 17209321 [TBL] [Abstract][Full Text] [Related]
23. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. Selwyn PA; Hartel D; Lewis VA; Schoenbaum EE; Vermund SH; Klein RS; Walker AT; Friedland GH N Engl J Med; 1989 Mar; 320(9):545-50. PubMed ID: 2915665 [TBL] [Abstract][Full Text] [Related]
24. Reducing tuberculosis incidence by tuberculin skin testing, preventive treatment, and antiretroviral therapy in an area of low tuberculosis transmission. Elzi L; Schlegel M; Weber R; Hirschel B; Cavassini M; Schmid P; Bernasconi E; Rickenbach M; Furrer H; Clin Infect Dis; 2007 Jan; 44(1):94-102. PubMed ID: 17143823 [TBL] [Abstract][Full Text] [Related]
25. High risk of active tuberculosis in HIV-infected drug users with cutaneous anergy. Selwyn PA; Sckell BM; Alcabes P; Friedland GH; Klein RS; Schoenbaum EE JAMA; 1992 Jul 22-29; 268(4):504-9. PubMed ID: 1619742 [TBL] [Abstract][Full Text] [Related]
26. Conventional tuberculin skin testing versus T-cell-based assays in the diagnosis of latent tuberculosis infection in HIV-positive patients. Hoffmann M; Reichmuth M; Fantelli K; Schoch OD; Fierz W; Furrer H; Vernazza P AIDS; 2007 Jan; 21(3):390-2. PubMed ID: 17255757 [No Abstract] [Full Text] [Related]
27. The level of PPD-specific IFN-gamma-producing CD4+ T cells in the blood predicts the in vivo response to PPD. Martins MV; Lima MC; Duppre NC; Matos HJ; Spencer JS; Brennan PJ; Sarno EN; Fonseca L; Pereira GM; Pessolani MC Tuberculosis (Edinb); 2007 May; 87(3):202-11. PubMed ID: 17049309 [TBL] [Abstract][Full Text] [Related]
28. Correlation of mucocutaneous manifestations of HIV/AIDS infection with CD4 counts and disease progression. Nnoruka EN; Chukwuka JC; Anisuiba B Int J Dermatol; 2007 Oct; 46 Suppl 2():14-8. PubMed ID: 17958624 [TBL] [Abstract][Full Text] [Related]
29. CD4+ and CD8+ lymphocytes and clinical features of HIV seropositive Nigerians on presentation. Onyemelukwe GC; Musa BO Afr J Med Med Sci; 2002 Sep; 31(3):229-33. PubMed ID: 12751562 [TBL] [Abstract][Full Text] [Related]
30. Two-stage tuberculin skin testing in an HIV-infected population: a preliminary report. Goldstein S; Perlman DC; Salomon N Mt Sinai J Med; 1994 Sep; 61(4):337-40. PubMed ID: 7969227 [TBL] [Abstract][Full Text] [Related]
31. Evaluation of the MycoDot test for the diagnosis of tuberculosis in HIV seropositive and seronegative patients. Ratanasuwan W; Kreiss JK; Nolan CM; Schaeffler BA; Suwanagool S; Tunsupasawasdikul S; Chuchottaworn C; Dejsomritrutai W; Foy HM Int J Tuberc Lung Dis; 1997 Jun; 1(3):259-64. PubMed ID: 9432374 [TBL] [Abstract][Full Text] [Related]
32. Correlation between CD4+ lymphocyte counts, concurrent antigen skin test and tuberculin skin test reactivity in human immunodeficiency virus type 1-infected and -uninfected children with tuberculosis. Madhi SA; Gray GE; Huebner RE; Sherman G; McKinnon D; Pettifor JM Pediatr Infect Dis J; 1999 Sep; 18(9):800-5. PubMed ID: 10493341 [TBL] [Abstract][Full Text] [Related]
33. Risk factors for transmission of Mycobacterium tuberculosis from HIV-infected tuberculosis patients, Botswana. Kenyon TA; Creek T; Laserson K; Makhoa M; Chimidza N; Mwasekaga M; Tappero J; Lockman S; Moeti T; Binkin N Int J Tuberc Lung Dis; 2002 Oct; 6(10):843-50. PubMed ID: 12365569 [TBL] [Abstract][Full Text] [Related]
34. Serum concentration of acute phase protein and lipid profile in HIV-1 seropositive patients and its relationship to the progression of the disease. Ogunro PS; Idogun ES; Ogungbamigbe TO; Ajala MO; Olowu OA Niger Postgrad Med J; 2008 Dec; 15(4):219-24. PubMed ID: 19169337 [TBL] [Abstract][Full Text] [Related]
35. Two-step tuberculin skin testing of injection drug users recruited from community-based settings. Lifson AR; Grant SM; Lorvick J; Pinto FD; He H; Thompson S; Keudell EG; Stark MJ; Booth RE; Watters JK Int J Tuberc Lung Dis; 1997 Apr; 1(2):128-34. PubMed ID: 9441076 [TBL] [Abstract][Full Text] [Related]
36. Lack of association of induration size with HIV infection among drug users reacting to tuberculin. Gourevitch MN; Hartel D; Schoenbaum EE; Klein RS Am J Respir Crit Care Med; 1996 Oct; 154(4 Pt 1):1029-33. PubMed ID: 8887602 [TBL] [Abstract][Full Text] [Related]
37. [Survival of patients with HIV-related tuberculosis. Study of mortality during the first 9 months of treatment]. Falqués Casanovas M; Langohr K; Gómez Melis G; García de Olalla Rizo P; Jansà López del Vallado JM; Caylà Buqueras JA Rev Esp Salud Publica; 1999; 73(5):549-62. PubMed ID: 10650746 [TBL] [Abstract][Full Text] [Related]
39. Spectrum of skin disorders in human immunodeficiency virus-infected patients in Singapore and the relationship to CD4 lymphocyte counts. Goh BK; Chan RK; Sen P; Theng CT; Tan HH; Wu YJ; Paton NI Int J Dermatol; 2007 Jul; 46(7):695-9. PubMed ID: 17614796 [TBL] [Abstract][Full Text] [Related]
40. Self-assessment of tuberculin skin test reactions by drug users with or at risk for human immunodeficiency virus infection. Gourevitch MN; Teeter R; Schoenbaum EE; Klein RS Int J Tuberc Lung Dis; 1999 Apr; 3(4):321-5. PubMed ID: 10206502 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]